Deciphera Pharmaceuticals, Inc. EPS - Earnings per Share 2018-2024 | DCPH
Deciphera Pharmaceuticals, Inc. eps - earnings per share from 2018 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Deciphera Pharmaceuticals, Inc. Annual EPS |
| 2023 |
$-2.29 |
| 2022 |
$-2.37 |
| 2021 |
$-5.16 |
| 2020 |
$-4.78 |
| 2019 |
$-4.48 |
| 2018 |
$-2.82 |
| 2017 |
$-2.99 |
| 2016 |
$-2.23 |
| 2015 |
$-4.67 |
| Deciphera Pharmaceuticals, Inc. Quarterly EPS |
| 2024-03-31 |
$-0.52 |
| 2023-12-31 |
$-0.54 |
| 2023-09-30 |
$-0.58 |
| 2023-06-30 |
$-0.57 |
| 2023-03-31 |
$-0.60 |
| 2022-12-31 |
$-0.42 |
| 2022-09-30 |
$-0.55 |
| 2022-06-30 |
$-0.60 |
| 2022-03-31 |
$-0.80 |
| 2021-12-31 |
$-1.52 |
| 2021-09-30 |
$-1.37 |
| 2021-06-30 |
$-1.21 |
| 2021-03-31 |
$-1.06 |
| 2020-12-31 |
$-1.09 |
| 2020-09-30 |
$-1.13 |
| 2020-06-30 |
$-1.20 |
| 2020-03-31 |
$-1.36 |
| 2019-12-31 |
$-1.39 |
| 2019-09-30 |
$-1.28 |
| 2019-06-30 |
$-0.56 |
| 2019-03-31 |
$-1.25 |
| 2018-12-31 |
$-0.86 |
| 2018-09-30 |
$-0.65 |
| 2018-06-30 |
$-0.65 |
| 2018-03-31 |
$-0.66 |
| 2017-12-31 |
$-0.38 |
| 2017-09-30 |
$-1.04 |
| 2017-06-30 |
$-0.91 |
| 2017-03-31 |
$-0.66 |
